Aclar®溶剂

Search documents
霍尼韦尔分拆Solstice材料业务,提交上市申请,瞄准可持续制冷与AI芯片市场
Sou Hu Cai Jing· 2025-08-28 15:40
Core Viewpoint - Honeywell has submitted Form 10 to the SEC for the planned spin-off of Solstice Advanced Materials, marking a significant step towards establishing Solstice as an independent, innovation-driven company [1][4]. Group 1: Business Positioning and Financial Data - Solstice is positioned as a differentiated high-performance materials company, serving as a leading supplier of refrigerants, semiconductor materials, protective fibers, and pharmaceutical packaging [5]. - The company aims to achieve sales of $3.8 billion and a net profit of $600 million in 2024, with an adjusted EBITDA of $1.1 billion [5]. Group 2: Operational Support Resources - Solstice is supported by multiple brands including Solstice®, Genetron®, Aclar®, Spectra®, Fluka®, and Hydranal®, with a workforce of 3,900 employees, 21 manufacturing sites, and 4 R&D centers [5]. Group 3: Long-term Development Direction - The company is committed to creating long-term value for stakeholders by collaborating with customers to seize structural growth opportunities, investing in innovation and manufacturing capabilities, and maintaining a resilient high-profit margin through the Solstice Accelerator operating model [5]. Group 4: Business Division Structure - Solstice will have two main business divisions: - Refrigerants and Application Solutions (RAS): Expected to generate $2.7 billion in sales in 2024, offering low global warming potential refrigerants, blowing agents, solvents, and aerosols under the Solstice®, Genetron®, and Aclar® brands [6]. - Electronics and Specialty Materials (ESM): Projected to achieve $1 billion in sales in 2024, focusing on electronic materials, industrial-grade fibers, laboratory life sciences materials, and specialty chemicals sold under the Spectra®, Fluka®, and Hydranal® brands [6].